The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.